From complexity to clarity in the microbiome Accelerate and transform discovery research and capitalize on the diverse opportunities of the microbiome with Diversigen. Diversigen provides comprehensive fee-for-service microbiome and metagenomics services focused on solutions to improve human, animal, and environmental health. Diversigen is at the forefront of setting industry standards for quality with a microbiome CLIA/CAP accredited, GLP compliant laboratory. Diversigen has extensive experience with highly diverse microbiome sample types and provides full project life cycle consulting services, building on research conducted at Baylor College of Medicine in the Alkek Center for Metagenomics and Microbiome Research. From pre-project consulting, study …

53 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

From Probiotics to PreciBiomics TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges. How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics. Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reshaping the future of crop protection and biotechnological production - Growth Without Compromise At SenseUP, we develop precision RNA solutions for sustainable plant protection and animal health that are effective, affordable and residue-free. As a spin-off of the renowned German Institute for Biotechnology at Forschungszentrum Jülich (FZJ), we have a strong foundation in scientific excellence. With our deep expertise and patented technologies, we utilise a Corynebacterium-based fermentative platform for the affordable and scalable production of encapsulated dsRNA. This active ingredient protects crops against insects, nematodes, fungi. Microbial strain-development, Fluorescence activated cell-sorting, Fermentation, High-throughput screening, RNA, dsRNA, Bioinsecticides, Biofungicides, Biopesticides, #sustainability …

147 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Dream ahead. RIBOPRO is an innovative service provider, producing high-quality, high-performance RNA products, which are used as powerful research tools and therapeutics. RiboPro offers both off-the-shelf and custom RNA products at competitive rates and turn-around times, effectively removing all barriers to successful use of RNA in the research and development of our customers. We have more than a decade of experience satisfying the RNA-related needs of almost 300 customers worldwide and thus we are confident that we can help you get your next project off to a good start. Let us worry about the quality and performance of your RNA, …

59 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

bluebird bio has rebranded as Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies for patients living with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. Follow our new page at the link below! gene therapy, gene addition, sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy

102 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Developing bacterial immunotherapies for oncology and infectious diseases. Microviable Therapeutics is a biotech company at pre-clinical stage, developing novel bacterial immunotherapies for oncology and AMR infectious diseases. Microviable was incorporated in 2016, as a spinoff of the Spanish National Research Council (CSIC). Microviable has received the European Seal of Excellence two times, a growing IP portfolio and numerous national and regional awards, and the certificate of Innovative SME. www.microviable.com Intestinal Microbiota, Intestinal disease, Clostridium difficile, Biotechnology, Microbiology, microbiota, microbiome, gut microbiota, gut health, probiotics, microbiota storage, microbiota isolation, GutAlive, anaerobes, human purified microbiota , biotherapeutics, and LBPs

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reporting on the latest Microbiome Scientific & Business Developments With over 100 trillion bacteria and other microbes estimated to inhibit the human body alone, we are seeing new knowledge and applications of microbiomes develop at an alarming rate, bringing with it new licensing agreements, large investments, IPOs, strategic partnerships and acquisitions across the Pharma and Human Health, Animal Health and Agriculture industries. Microbiome TimesTM aims to assist science entrepreneurs to acquire insights that will expand the envelope of applied microbiome knowledge and offers a one-stop-shop to stay up to date with this fast paced industry. Pharmaceuticals, Human Health, Microbiome, Probiotics, …

60 similar entities Type: Startup Activities: deeptech biotech healthtech

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San Carlos, CA. Microbial Therapeutics, Host Microbe Interactions, Human Microbiome, and Pharmaceutical Development

271 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science-driven efficacy Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Muscle-Wasting Diseases. For over 15 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Diabetes, MASLD/MASH, Atherosclerosis, Binge-eating, IBD, Sarcopenia, Cachexia, Duchenne Muscular Dystrophy (DMD)... Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and muscle-wasting spaces. Localisation : Marseille - France preclinical, obesity, diabetes, gastrointestinal disorders, tailor-made rodent …

55 similar entities Type: Startup Activities: deeptech

Developing precision RNA-based gene regulating therapies RNatives is a biotechnology company developing precision RNA-based gene regulating therapies by leveraging its RNAIntel platform which identifies small non-coding RNAs that bind directly to gene promoters to regulate gene expression. The Company is developing novel RNA-based therapies to treat ocular, CNS, and metabolic diseases, as well as cancer. The Company's technology is based on years of academic research published by Turunen et al.

59 similar entities Type: Startup Activities: biotech deeptech

Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification

106 similar entities Type: Startup Activities: biotech foodtech Technologies: Synthetic Biology

Pioneering RNA cell therapy for autoimmune disease Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis with plans to initiate a Phase 2 trial in myositis. For more information, please visit www.cartesiantherapeutics.com. Immunotherapy, Oncology, Molecular Biology, Immunology, Myasthenia Gravis, ARDS, Cell Therapy, NETs, Gene Therapy, Cancer Research, multiple myeloma, SLE, mRNA, CAR-T, Systemic lupus erythematosus, Autoimmunity, Autoimmune Disease, and Lupus

293 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reimagining ADCs. Tubulis is now part of Gilead Sciences. Gilead is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. For more information on Gilead, please visit www.gilead.com and follow @GileadSciences on LinkedIn for updates. Note: Comments on the Tubulis LinkedIn page are not actively monitored. Antibody Drug Conjugates, Targeted Therapy, Biotechnology, and Drug Development

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing cancer care through microbiome profiling 🦠 Discover your microbiome: www.mybioma.com Biome Diagnostics GmbH (BiomeDx®) is an Austria-based MedTech company driving precision medicine through pioneering microbiome-based technologies that transform cancer care. At the intersection of state-of-the-art DNA sequencing and advanced machine learning, BiomeDx® develops first-in-class solutions for routine clinical practice. In addition to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on medically certified products in the fields of gut microbiome and cancer. With ISO 9001 and ISO 13485 certifications, BiomeDx® is the first microbiome company worldwide with dual ISO certification — reflecting our commitment to safety and …

79 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology A.I. A.I. - Machine Learning

Reimagining known biology to deliver high impact medicines Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Pharmaceuticals, Liver Disease, Life Sciences, BioPharmaceuticals, CML, Oncology, and HemOnc

343 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

PhageX is a young biotech that develops smart antibiotics for microbiome precision-editing. PhageX is a laureate of the Worldwide Innovation Challenge and Concours National d'Aide à la Création d'Entreprise Innovante. We are currently incubated at Institut Pasteur in Paris.

60 similar entities Type: Startup Activities: deeptech Technologies: IoT

Kane Biotech has a portfolio of proprietary commercialized products that prevent and remove microbial biofilms. Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds which results in serious clinical outcomes and significant cost. revyve® addresses both biofilms and wound bacteria. revyve® Antimicrobial Wound Gel and revyve® Antimicrobial Wound Gel Spray are US FDA 510(k) cleared. revyve® Antimicrobial Wound Gel is Health Canada approved. revyveTM, revyve®, DispersinB®, coactiv+TM, coactiv+®, DermaKBTM and DermaKB BiofilmTM are trademarks of Kane Biotech. The company is listed on …

61 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: IoT

Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance. antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA

71 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in …

137 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI

267 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology

Pioneering drug discovery company exploiting cutting edge technologies to create best-in-class small molecule medicines C4XD is a pioneering Drug Discovery company, combining scientific expertise with cutting-edge technologies to efficiently deliver world‐leading medicines. We have a highly valuable and differentiated approach to Drug Discovery through our enhanced molecular design and patient stratification capabilities, generating small molecule drug candidates across multiple disease indications focused on immuno-inflammation. The Company was founded as a spin-out from the University of Manchester. It has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically and have enabled C4XD …

295 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition …

129 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche …

109 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Mark Smith and Stephen Cork were appointed Administrators on 21 August 2024, and act without personal liability. Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections …

236 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug …

207 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a SIX listed (BIOV) clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s two in house technology platforms: i) TRIC and ii)Ansamycin chemistry, BioVersys develops novel, innovative antibacterial drugs, overcoming resistance and modulating the microbiome. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our most advanced research and development programmes address nosocomial …

63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Enhancing digestive health GoodGut is a biotechnology company focused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota. We aim to provide technological tools that will help to obtain a faster, more reliable and lower cost medical diagnosis than existing methods, alongside therapies to improve the quality of life of patients with compromised digestive health. The company was created in 2014 as a spin-off of the University of Girona (UdG) and the Institute of Biomedical Research of Girona Dr. Josep Trueta (IdIBGi). Our facilities can be found …

163 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovative Manufacturing Services (IMFS).

176 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

258 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

298 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Together, make science greater! 🧫Smaltis — More than a laboratory, your partner for innovating & mastering microbiology. We are a private laboratory specializing in microbiology, delivering advanced and tailor-made solutions to support your research projects and ensure the performance of your microbiological products and processes, whether they relate to health, agri-environmental sectors, or industry. With our two complementary divisions — 🔬 Research Microbiology and 🧪 Precision Microbiology — we cover every stage of your projects, from design to application, delivering controlled, traceable, and actionable data. Our expertise spans the fields of antimicrobials, microbiota, genetic engineering, and genomics. This unique, comprehensive …

112 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Empowering the Health Microbiome Movement The gut microbiome (i.e: the microorganisms present in our intestine) plays a major role in maintaining our health. In case of dysfunction, the microbiome is linked to a large number of inflammatory, metabolic, and neurological diseases. The study of the microbiome opens many perspectives for tomorrow’s medicine. Pelican Health offers a solution enabling multiple sampling of the microbiome in-situ with a single oral administration, in a reliable, precise, simple to administer and non-invasive manner.

47 similar entities Type: Startup Activities: deeptech

Biomanufacturing services Naobios is a Contract Development and Manufacturing Organization (CDMO) providing bioprocess development and offering GMP production of clinical batches of BSL2/BSL3 viral vaccines, oncolytic viruses, viral vectors and human viral challenge agents. Naobios joined the Clean Biologics group in 2019. Having built up 20 years’ experience in bioprocess development, Naobios helps its clients to bring their drug candidates to the clinical stage as rapidly as possible – at the highest level of quality – whilst building on its technical know-how in scalable and industrial processes. With its adaptability and range of skills, the company can lead a project …

59 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from Université Côte d'Azur, INSERM and CNRS focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, …

171 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Accelerate your innovation with your clinical and microbiome partner! A leading C.R.O specialised in designing and running of experimental, pre-clinical sample analysis and clinical research projects, with a unique nutrition and microbiome analytical service: • Internal Clinical Investigation Centers and Central Lab capabilities, • Management of local and multi-center projects, • Extensive experience with microbiota tool box and metagenomics services, from sample collection to analytical processes and biostatistics. BIOFORTIS GROUP With over 20 years of expertise, the Biofortis Group is an international CRO and consulting organization specialized in services dedicated to health and innovation. Built on three complementary entities - …

130 similar entities Type: SMB Activities: deeptech Technologies: SaaS

Microbial solutions and microbiome skincare with live bacteria In Lactobio we focus on the creation of new microbiome and microbial solutions to target and fight the problem of increasing infections caused by microorganisms being resistant to antibiotics. We work with the skin, vaginal, and gut microbiota to treat a variety of diseases – with projects spanning various pathogens. Lactobio has obtained very promising clinical results, with isolated lactic acid bacteria having a significant antibacterial activity against Staphylococcus aureus, Methicillin Resistant Staphylococcus aureus (MRSA) and other pathogens.

55 similar entities Type: Startup Activities: deeptech biotech

Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our …

443 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK The PetMedix channel will soon be discontinued as we join forces with Zoetis. Follow the Zoetis channels to stay connected and for the latest updates! Biotechnology, Drug Development, Drug Discovery, Therapeutic Antibodies, Monoclonal Antibodies, Companion Animal, Veterinary Medicine, and Research and Development

77 similar entities Type: Startup Activities: pettech biotech deeptech Technologies: Synthetic Biology

AveXis is now Novartis Gene Therapies Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/ How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947 Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy

221 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Evolution. Adaptation. Future. Phage-based solutions to combat bacteria. - Prevention - Diagnosis - Treatment "One Health" personalized treatments. biotecnología, microbiología, investigación, biomedicina, bacteria, phage, and phage therapy

185 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City …

66 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: healthtech biotech deeptech

SHIME technology & preclinical gastrointestinal expertise We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to (functional) food, feed and pharma industry. A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailormade solutions support your research from early phases to the final stages of product development. ProDigest is the company that brings on the market the SHIME® platform (Simulator of the Human Intestinal Microbial Ecosystem) and related technologies (Colon-on-a-plate®; Diamod®; MetaKey®) Gastrointestinal microbial ecology, Clinical trials, Molecular analyses, In vitro …

70 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS

Building new therapies atom by atom. Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase …

68 similar entities Type: SMB Activities: nanotech deeptech biotech Technologies: Synthetic Biology

Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO

127 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

385 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Microbiome-Driven Skin Health & Personal Care Innovation HelloBiome is a B2B biotech platform specializing in microbiome data collection, clinical research, and AI-driven analytics for consumer health and beauty. We support brands, ingredient suppliers, and manufacturers in translating clinical microbiome data into actionable insights, validated claims, and targeted product development. Our platform combines non-invasive microbiome sampling, large-scale clinical studies, and proprietary AI models to redefine skin, scalp, and body profiling beyond traditional typologies. Trusted by global industry leaders, HelloBiome operates at the intersection of microbiome science, clinical research, and applied AI to build the next generation of data-driven consumer health solutions. …

83 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Bioproduction at scale Enduro is a biotech startup improving large-scale fermentations. We help biotech companies enhance large-scale fermentations, bringing products cheaper and faster to market. Our proprietary platform Enduro Sense reprograms cells to improve population heterogeneity and endurance of production. Enduro Sense is seamlessly integrated, self-selecting technology that addicts microbial cells to production. EnduroSense is easily integrated across host organisms. We welcome inquiries to test Enduro Sense. Get in touch at info@endurogenetics.com or visit our website.

56 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

337 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

FEED our Population PROTECT our Health PRESERVE our Environment AuraLIP propose la nouvelle génération d’ingrédients fermentés comme alternative à la protéine animale. Vous êtes un acteur alimentaire en recherche de solutions innovantes à impact RSE ? Contacter nous : contact@auralip.com #probiotics #plantbased #alternativeprotein #rse #ferment

62 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in …

270 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: …

98 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Unlocking human potential with breakthrough mammary biotechnology. BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies. Femtech, Biotechnology, infant nutrition, Social Venture, and Female Founder

61 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines

206 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Smarter antibiotics for a healthier tomorrow. smartbax is a German biotech startup, founded in Munich in 2021, dedicated to developing innovative antibiotics to combat the rising threat of multidrug-resistant bacteria. Our vision is to create smarter antibiotics for a healthier tomorrow. By combining cutting-edge technology with deep scientific expertise, our team designs drugs to outsmart bacterial resistance – addressing one of the most urgent threats to global health. At smartbax, we believe preventing a crisis tomorrow means taking action today. antibiotics

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which protects against common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms and soothes sore throat. Our head office is in Lund, Sweden, but we also have an office in Reykjavik, Iceland. For product info, please visit at www.coldzyme.co.uk. Cold and Flu, Enzyme (trypsin), and Barrier technology

219 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

rethinking microbiome Mikrobiomik is a biopharmaceutical company created for the research and development of therapies based on the human microbiome. Our Mission At Mikrobiomik we develop innovative therapies based on intestinal microbiota to offer new therapeutic options in serious diseases with unmet medical needs. Through our FSPIM® technology, we work to restore the balance of the microbiome and provide healthcare professionals and patients with safe, standardized and accessible therapeutic solutions in clinical practice. Fecal microbiota transplant (FMT)

63 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics

221 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming Labs with AI and Automation Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on …

135 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics

Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development

248 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

We are a specialist respiratory biotech company focused on severe viral lung infections Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com.

73 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Exosome-based therapeutics Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for the treatment of severe lung inflammation, a condition with limited treatment options and a common cause of death following SARS‐CoV‐2 infection. Contact us at team@exogenus-t.com Biotechnology, Regenerative Medicine, Stem cells, exosomes, cell biology, and therapies

293 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Orchestrating gut health® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

143 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our progress: https://lnkd.in/eCH3d6ay

153 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

535 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

Driving Bio-Industry Growth as Michigan's only state-wide life-sciences association. The Advocate for Michigan's bio-industry! MichBio is a non-profit association representing more than 600 bioscience companies, universities and academic institutions dedicated to advancing Michigan's bioscience industry. MichBio is the state's leading advocate for the bio-industry. MichBio fosters an environment that educates the public and policy makers, influences public policy and advances the economic interests of its member companies and the industry as a whole. Creating Value, Building Networks, Impacting Policy, and Growing Talent

53 similar entities Type: SMB Activities: biotech deeptech

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner Biodesix is a leading diagnostics solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. Our culture: The foundation of Biodesix workplace culture is based on these operating principles: TEAM. IMPACT. EXCELLENCE. Based on anonymous …

60 similar entities Type: SMB Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite

58 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

From replacement to regeneration osteobionix is a company dedicated to advancing the standards of care for people suffering from cartilage or bone loss. Cartilage and bone loss may result from a variety of causes including osteoarthritis, trauma and tumor and can severely affect a person’s lifestyle. osteobionix wants to provide people suffering from cartilage or bone loss with innovative, high quality, proven, customized solutions, which can help them regain the lifestyle they deserve. osteobionix collaborates with surgeons in designing and manufacturing reliable, cost-effective solutions, which take into account the uniqueness and complexity of each single surgical case. osteobionix strives to …

58 similar entities Type: SMB Activities: deeptech manufacturing Technologies: 3D Printing Synthetic Biology

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

282 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Sterile Solutions, Built Differently. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health Subscribe our newsletter: www.ten23.health/ten23-health-newsletter biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

412 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

284 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

BioCryst Pharmaceuticals is a commercial-stage biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina, we have a regional office in Boston, Massachusetts, and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and …

409 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

HIRING! Biotech makes the world a better place to live, so we’re making labs that are a better place to work. With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work. We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money. Our BioHotel labs are designed with biotech startups in mind: - Short term, flexible leases - Central London locations …

59 similar entities Type: Startup Activities: biotech deeptech

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production. PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This …

92 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Original preparations, generics, biosimilars and licensed products: Gedeon Richter stands worldwide for effective, modern and affordable therapies. With a focus on sustainable growth, the company continually invests in research and development, the highest manufacturing quality and digitalization to further advance medical innovations. Gedeon Richter has been active in gynecology in Germany since 2011 and is one of the leading providers in women's health. With the establishment of the new biotechnology unit in 2024, the company is also further expanding its activities in the biosimilar sector. Supported by the largest R&D center in Hungary, Gedeon Richter aims to act as a …

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

257 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing

174 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies

263 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Study of molecular mechanisms governing the functioning of prokaryotes 🧫 The LCB, created in 1962, is a mixed research unit between CNRS and Aix Marseille University located on the Joseph Aiguier campus within the Institut de Microbiologie de la Méditerranée 🧬 The laboratory hosts twelve teams all studying the functioning of bacteria at the molecular, cellular, multicellular and ecological levels 🔬 The bacterial species under study are chosen to explore core mechanisms of adaptation, enabling bacteria to sense their environment and form complex multicellular consortia. In particular, the laboratory’s teams are interested in the interactions between bacteria and their hosts, …

47 similar entities Type: SMB Activities: deeptech

All cancer/testis antigens, neoantigens and infectious disease antigens off-the-shelf and customized At peptides&elephants, we offer custom peptide synthesis and a comprehensive collection of catalog peptides for immune research, synthesized by our in-house developed peptide synthesis robots. By controlling every step, we continuously optimize and accelerate the synthesis process. With 25 years of experience in peptide synthesis and robotics, we deliver high-quality peptides promptly and efficiently, ensuring complete customer satisfaction. Visit our peptide shop to discover our extensive collection of catalog peptides! As a dedicated team of highly qualified individuals we are also ready to meet your most challenging requirements in …

67 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming translational medicine with 3D microtissue screening to accelerate human-relevant drug discovery Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from UL in 2017 and has been based in Shannon, Co. Clare, Ireland since 2019. To date, Hooke Bio have been awarded up to 12M in investment from a combination of private, angel and public funds. A portion of this has come from the prestigious European Innovation Council (EIC) Accelerator funding of which Hooke was …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We are a Franco-Brazilian company dedicated to proposing specialized solutions for your needs in the area of ​​biotechnology and research. Biotika Biotechnology aims to import and distribute reagents and equipment with biotechnological innovation to institutions and professionals in the field of scientific research, working under the relevant legislation established by ANVISA (National Health Surveillance Agency). In Brazil, we have an office in the city of São Paulo and a technical team trained to respond to requests from throughout the national and South American territory. In France, we have another one in Annecy LE Vieux, through which direct import purchase requests …

55 similar entities Type: Startup Activities: manufacturing deeptech

Together, we can solve the toughest challenges in drug delivery. Since October 2023, Qualicaps capsule manufacturing has been part of Roquette, a global leader of plant-based ingredients for health and nutrition markets that operates in more than 100 countries, through more than 40 manufacturing sites, and employs more than 11,000 people worldwide. For more information about Roquette, visit: www.roquette.com Capsules and Equipment

42 similar entities Type: Startup Activities: manufacturing industry 4.0 Technologies: Synthetic Biology

We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

281 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Business developer for life sciences in the Stuttgart & Neckar-Alb BioRegio STERN Management GmbH has been working as an economic developer for the life sciences since 2001. It promotes innovations, start-ups and small and medium-sized companies on a public mission. It is a central contact point for founders and entrepreneurs from the areas of biotechnology and medical technology and also from cooperating high-tech sectors such as automation and IT. The STERN BioRegion with the Stuttgart and Neckar-Alb regions and the cities of Tübingen and Reutlingen is home to over 120 medium-sized medical technology companies. The combination of established family businesses, …

46 similar entities Type: SMB Activities: deeptech

be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. …

61 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, …

433 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

418 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Expert in microbiota and biofilm BioFilm Control is a French biotech company expert in microbiota and biofilm since 2005. We work with R&D laboratories and marketing departments of pharmaceutical, cosmetic, oral care, veterinary, food, hygiene and food supplement industries to help them characterize and optimize the activity of their products on microbiota.

61 similar entities Type: SMB Activities: biotech deeptech

BDI biotech provides biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields. At BDI biotech we provide biotechnological services and solutions in the Cosmetic and Nutraceutical fields, providing as well LBP production, to bring ideas from bench to reality. We work as an external R&D department specialized in strain and bioprocess development (production, recovery and/or its application), scale-up and regular batches productions. Our Services: 1) Strain Selection & Improvement. Whether it's yeast, fungi, or bacteria, we provide the tools and services to increase byproduct or biomass production. 2) BioProcess Development & Scale-Up: BDI biotech has strong expertise …

159 similar entities Type: Startup Activities: biotech deeptech cosmetics Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Investing dark biodiversity DEINOVE is a French biotechnology company pioneering the exploration of a new domain of life, unexplored at 99.9%: the microbial dark matter. By revealing the metabolic potential of rare bacteria or still classified as uncultivable, it tackles a global health and economic challenge: antimicrobial resistance. The new therapies discovered and developed by DEINOVE (antibiotics, antifungals, antivirals and antiparasitics) target superbugs (microbes that resist to one or several antimicrobials) that cause life-threatening infections which are now spreading at high speed. This breakthrough approach gave birth to one of the World first specialized micro-biotechnology platforms and a unique collection …

72 similar entities Type: SMB Activities: biotech deeptech

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions. MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company focused on the $142 Billion WW dermatology and skin care market. We are developing therapies for the top 5 dermatology & skin care conditions - Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which have a huge impact on quality of life. More than 230 million patients suffer from these 5 skin diseases, which represent a $12.9 Billion Rx market and a $121 Billion skin care market. MatriSys Bio’s scientific approach is to rebalance the natural skin microbiome by application of microbial …

65 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Bio sourced materials

Transforming the way challenging diseases and conditions are treated. Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located at RIDC Park, in the Fox Chapel area of Pittsburgh. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single …

61 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Worldwide Biotech Company Database BioPharmGuy is a website that functions as a directory of companies in the biotechnology, pharmaceutical, medical device & life science industries. We offer services for businesses as well as job seekers. The site is constantly being updated to ensure we have the most accurate and high quality, free-to-use database.

84 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology